Two brands of fecal immunochemical tests were equally accurate in detecting advanced neoplasia, according to data from a head-to-head trial published in Gastroenterology.
Manon C. W. Spaander, MD, PhD, of Erasmus MC University Medical Center in Rotterdam, the Netherlands, and colleagues wrote that FITs are becoming the norm in population screening for colorectal cancer, but the lack of studies comparing different brands has made it difficult to choose the right one.
“In the European guidelines, the quantitative immunochemical tests are recommended as test of choice for population screening,”

Source link